1 | dosage | 6,290 |
2 | price | 732 |
3 | fluence | 111 |
4 | irradiance | 96 |
5 | dimensionality | 77 |
6 | dose-intensity | 54 |
7 | humidex | 25 |
8 | tautomeric | 24 |
9 | six-dose | 23 |
10 | posology | 20 |
11 | thiolate | 20 |
12 | pile | 18 |
13 | dose-range | 17 |
14 | case-report | 15 |
15 | thione | 14 |
16 | dose-reduction | 12 |
17 | growth-rate | 11 |
18 | tranquilizer | 11 |
19 | age-range | 9 |
20 | runtime | 8 |
21 | glargine-based | 7 |
22 | vp-16/cddp | 7 |
23 | subsidization | 6 |
24 | endoflagellar | 5 |
25 | 25-fraction | 4 |
26 | dose/schedule | 4 |
27 | mononucleates | 4 |
28 | angiosome | 3 |
29 | av-delay | 3 |
30 | clarithromycin-amoxicillin-omeprazole | 3 |
31 | ip+sy | 3 |
32 | oralet | 3 |
33 | single-dosage | 3 |
34 | two-doses | 3 |
35 | α-selectivity | 3 |
36 | 'overview | 2 |
37 | 2nrti+nnrti | 2 |
38 | aminopropanol | 2 |
39 | cnnm2a | 2 |
40 | counter-ions | 2 |
41 | dose/frequency | 2 |
42 | four-times-a-day | 2 |
43 | min-r | 2 |
44 | mitoxantrone-containing | 2 |
45 | start-of-relapse | 2 |
46 | treatment-strategies | 2 |
47 | val851 | 2 |
48 | 'pyrolysis | 1 |
49 | 'reasonable | 1 |
50 | 11h/night | 1 |
51 | 42-residue | 1 |
52 | antideaminated | 1 |
53 | b4n4 | 1 |
54 | biphenyldiol-/nad-bound | 1 |
55 | bronchorreic | 1 |
56 | caries-control | 1 |
57 | d-dimerthreshold | 1 |
58 | diesterified | 1 |
59 | disulphate | 1 |
60 | epimastiogote | 1 |
61 | evaluation/feedback | 1 |
62 | ferroni | 1 |
63 | glycine-extended | 1 |
64 | group.after | 1 |
65 | hardiest | 1 |
66 | kenward-roger | 1 |
67 | lambda1 | 1 |
68 | low-harm | 1 |
69 | membrane-free | 1 |
70 | microsuction | 1 |
71 | multiple-test | 1 |
72 | nano-dosage | 1 |
73 | non-delusive | 1 |
74 | non-neutralised | 1 |
75 | nonmeningeal | 1 |
76 | not-so-rare | 1 |
77 | poligenetic | 1 |
78 | pustular-midsole | 1 |
79 | quasipolynomial | 1 |
80 | scale-long | 1 |
81 | sdx-pyrimethamine | 1 |
82 | secretion-competent | 1 |
83 | self-organizational | 1 |
84 | ssp1-gfp | 1 |
85 | strength/dosage | 1 |
86 | sulfate-soaked | 1 |
87 | ta-dependent | 1 |
88 | treatment/life | 1 |
89 | turkish-fertility | 1 |
90 | tyr-bound | 1 |
91 | worldsheet | 1 |
92 | zn-loaded | 1 |
1 | 'overview | 2 |
2 | 'pyrolysis | 1 |
3 | 'reasonable | 1 |
4 | 11h/night | 1 |
5 | 25-fraction | 4 |
6 | 2nrti+nnrti | 2 |
7 | 42-residue | 1 |
8 | age-range | 9 |
9 | aminopropanol | 2 |
10 | angiosome | 3 |
11 | antideaminated | 1 |
12 | av-delay | 3 |
13 | b4n4 | 1 |
14 | biphenyldiol-/nad-bound | 1 |
15 | bronchorreic | 1 |
16 | caries-control | 1 |
17 | case-report | 15 |
18 | clarithromycin-amoxicillin-omeprazole | 3 |
19 | cnnm2a | 2 |
20 | counter-ions | 2 |
21 | d-dimerthreshold | 1 |
22 | diesterified | 1 |
23 | dimensionality | 77 |
24 | disulphate | 1 |
25 | dosage | 6,290 |
26 | dose-intensity | 54 |
27 | dose-range | 17 |
28 | dose-reduction | 12 |
29 | dose/frequency | 2 |
30 | dose/schedule | 4 |
31 | endoflagellar | 5 |
32 | epimastiogote | 1 |
33 | evaluation/feedback | 1 |
34 | ferroni | 1 |
35 | fluence | 111 |
36 | four-times-a-day | 2 |
37 | glargine-based | 7 |
38 | glycine-extended | 1 |
39 | group.after | 1 |
40 | growth-rate | 11 |
41 | hardiest | 1 |
42 | humidex | 25 |
43 | ip+sy | 3 |
44 | irradiance | 96 |
45 | kenward-roger | 1 |
46 | lambda1 | 1 |
47 | low-harm | 1 |
48 | membrane-free | 1 |
49 | microsuction | 1 |
50 | min-r | 2 |
51 | mitoxantrone-containing | 2 |
52 | mononucleates | 4 |
53 | multiple-test | 1 |
54 | nano-dosage | 1 |
55 | non-delusive | 1 |
56 | non-neutralised | 1 |
57 | nonmeningeal | 1 |
58 | not-so-rare | 1 |
59 | oralet | 3 |
60 | pile | 18 |
61 | poligenetic | 1 |
62 | posology | 20 |
63 | price | 732 |
64 | pustular-midsole | 1 |
65 | quasipolynomial | 1 |
66 | runtime | 8 |
67 | scale-long | 1 |
68 | sdx-pyrimethamine | 1 |
69 | secretion-competent | 1 |
70 | self-organizational | 1 |
71 | single-dosage | 3 |
72 | six-dose | 23 |
73 | ssp1-gfp | 1 |
74 | start-of-relapse | 2 |
75 | strength/dosage | 1 |
76 | subsidization | 6 |
77 | sulfate-soaked | 1 |
78 | ta-dependent | 1 |
79 | tautomeric | 24 |
80 | thiolate | 20 |
81 | thione | 14 |
82 | tranquilizer | 11 |
83 | treatment-strategies | 2 |
84 | treatment/life | 1 |
85 | turkish-fertility | 1 |
86 | two-doses | 3 |
87 | tyr-bound | 1 |
88 | val851 | 2 |
89 | vp-16/cddp | 7 |
90 | worldsheet | 1 |
91 | zn-loaded | 1 |
92 | α-selectivity | 3 |
1 | val851 | 2 |
2 | lambda1 | 1 |
3 | b4n4 | 1 |
4 | cnnm2a | 2 |
5 | bronchorreic | 1 |
6 | tautomeric | 24 |
7 | poligenetic | 1 |
8 | zn-loaded | 1 |
9 | glycine-extended | 1 |
10 | diesterified | 1 |
11 | sulfate-soaked | 1 |
12 | glargine-based | 7 |
13 | non-neutralised | 1 |
14 | antideaminated | 1 |
15 | d-dimerthreshold | 1 |
16 | biphenyldiol-/nad-bound | 1 |
17 | tyr-bound | 1 |
18 | price | 732 |
19 | irradiance | 96 |
20 | fluence | 111 |
21 | membrane-free | 1 |
22 | treatment/life | 1 |
23 | dosage | 6,290 |
24 | single-dosage | 3 |
25 | nano-dosage | 1 |
26 | strength/dosage | 1 |
27 | age-range | 9 |
28 | dose-range | 17 |
29 | 'reasonable | 1 |
30 | pile | 18 |
31 | pustular-midsole | 1 |
32 | clarithromycin-amoxicillin-omeprazole | 3 |
33 | dose/schedule | 4 |
34 | runtime | 8 |
35 | angiosome | 3 |
36 | sdx-pyrimethamine | 1 |
37 | thione | 14 |
38 | not-so-rare | 1 |
39 | six-dose | 23 |
40 | start-of-relapse | 2 |
41 | disulphate | 1 |
42 | thiolate | 20 |
43 | growth-rate | 11 |
44 | epimastiogote | 1 |
45 | 42-residue | 1 |
46 | non-delusive | 1 |
47 | mitoxantrone-containing | 2 |
48 | scale-long | 1 |
49 | ferroni | 1 |
50 | 2nrti+nnrti | 2 |
51 | evaluation/feedback | 1 |
52 | nonmeningeal | 1 |
53 | quasipolynomial | 1 |
54 | self-organizational | 1 |
55 | aminopropanol | 2 |
56 | caries-control | 1 |
57 | low-harm | 1 |
58 | subsidization | 6 |
59 | 25-fraction | 4 |
60 | dose-reduction | 12 |
61 | microsuction | 1 |
62 | vp-16/cddp | 7 |
63 | ssp1-gfp | 1 |
64 | min-r | 2 |
65 | endoflagellar | 5 |
66 | kenward-roger | 1 |
67 | group.after | 1 |
68 | tranquilizer | 11 |
69 | treatment-strategies | 2 |
70 | two-doses | 3 |
71 | mononucleates | 4 |
72 | 'pyrolysis | 1 |
73 | counter-ions | 2 |
74 | worldsheet | 1 |
75 | oralet | 3 |
76 | 11h/night | 1 |
77 | ta-dependent | 1 |
78 | secretion-competent | 1 |
79 | case-report | 15 |
80 | hardiest | 1 |
81 | multiple-test | 1 |
82 | 'overview | 2 |
83 | humidex | 25 |
84 | four-times-a-day | 2 |
85 | av-delay | 3 |
86 | dose/frequency | 2 |
87 | posology | 20 |
88 | ip+sy | 3 |
89 | dimensionality | 77 |
90 | turkish-fertility | 1 |
91 | dose-intensity | 54 |
92 | α-selectivity | 3 |